HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nitric oxide has no obligatory role in isoflurane late preconditioning against myocardial stunning.

AbstractAIMS:
Isoflurane has been demonstrated to produce late preconditioning against myocardial stunning. We tested the hypothesis that this effect is dependent upon an increased production of nitric oxide.
MAIN METHODS:
Studies were performed in 18 conscious dogs, chronically instrumented to measure coronary blood flow and myocardial wall thickening (WT). In Group 1 (control; n=7), a 10-min coronary occlusion was produced followed by reperfusion; WT was monitored until full recovery. In Group 2 (n=6), the same occlusion-reperfusion protocol was performed 24h after inhalation of 1 MAC isoflurane (1.4% in O(2)) for 60 min. In Group 3 (n=5), the late anti-stunning effect of isoflurane was evaluated following non-selective inhibition of NOS with N-nitro-l-arginine (l-NA, 30 mg/kg on 3 days beginning 1 day prior to isoflurane). Expression of eNOS and iNOS protein was measured by Western blotting.
KEY FINDINGS:
Two to 3h of reperfusion was required for recovery of WT following isoflurane (Group 2). In contrast, without isoflurane (Group 1), WT remained markedly reduced (30% below baseline) at this time point and required more than 6h of reperfusion for recovery. Treatment with l-NA (Group 3) did not alter time-course of recovery of WT following isoflurane. Isoflurane caused an increased expression of eNOS, but not of iNOS.
SIGNIFICANCE:
Isoflurane produced late preconditioning against myocardial stunning. Although this effect was associated with an up-regulation of eNOS, its persistence following l-NA suggested that an increased production of nitric oxide did not play an obligatory role.
AuthorsSong-Jung Kim, Gautam Malik, Maged M Saad, Sung-Ho Yoon, Joaquin B Gonzalez, George J Crystal
JournalLife sciences (Life Sci) Vol. 91 Issue 23-24 Pg. 1201-6 (Dec 10 2012) ISSN: 1879-0631 [Electronic] Netherlands
PMID23044225 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • Nitroarginine
  • Nitric Oxide
  • Isoflurane
  • Nitric Oxide Synthase Type II
Topics
  • Animals
  • Blood Flow Velocity
  • Blotting, Western
  • Dogs
  • Ischemic Preconditioning, Myocardial (methods)
  • Isoflurane (pharmacology)
  • Myocardial Stunning (prevention & control)
  • Nitric Oxide (metabolism)
  • Nitric Oxide Synthase Type II (antagonists & inhibitors)
  • Nitroarginine (pharmacology)
  • Reperfusion (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: